• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM Back to Search Results
Catalog Number 1011539-18
Device Problems Material Rupture (1546); Difficult or Delayed Activation (2577)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/23/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that the procedure was performed to treat a 90% stenosed, narrow, and concentric re-stenosed lesion in the mid renal artery.A 7x18mm rx herculink elite stent system was being used per the instructions for use to treat restenosis; however, during an attempt to inflate the balloon an inability to ramp up and hold pressure in the balloon was observed.The stent partially deployed at the ends, but not completely.The delivery system was removed and an unknown balloon catheter was advanced and used to successfully post-dilate the stent to its full diameter.The case was finished with good results.There were no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Internal file number - (b)(4).Evaluation summary: visual and functional inspections were performed.The reported balloon rupture was unable to be confirmed as the balloon was able to inflate and hold pressure without any ruptures noted.The reported difficulty to deploy was unable to be confirmed as the stent implant was deployed during the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.The investigation was determined the reported difficulty to deploy and balloon rupture appear to be related to circumstances of the procedure.The noted tearing of the guide wire exit notch appears to have resulted from manipulation and/or interaction with the guide wire.This type of mechanical damage can occur if the guide wire and stent delivery device are pull in opposite direction causing the tearing at the guide wire exit notch resulting in the inability to deploy the balloon and stent.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8609628
MDR Text Key145031912
Report Number2024168-2019-03797
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2021
Device Catalogue Number1011539-18
Device Lot Number8091361
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/29/2019
Initial Date Manufacturer Received 04/23/2019
Initial Date FDA Received05/14/2019
Supplement Dates Manufacturer Received06/20/2019
Supplement Dates FDA Received06/27/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
-
-